Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03412784

Ligand	Ligand name	Chain	PDB	Tanimoto
MU0	(5S)-N-[(1S,2S,4S)-1-BENZYL-2-HYDROXY-4-{[(2S)-3-METHYL-2-(2-OXOTETRAHYDROPYRIMIDIN-1(2H)-YL)BUTANOYL]AMINO}-5-PHENYLPENTYL]-2-OXO-3-PHENYL-1,3-OXAZOLIDINE-5-CARBOXAMIDE	A,B	2Q55	0.72
INH	N-(R-CARBOXY-ETHYL)-ALPHA-(S)-(2-PHENYLETHYL)GLYCYL-L-ARGININE-N-PHENYLAMIDE	A	1SLN	0.71
INH	N-(R-CARBOXY-ETHYL)-ALPHA-(S)-(2-PHENYLETHYL)GLYCYL-L-ARGININE-N-PHENYLAMIDE	A	2SRT	0.71
INH	N-(R-CARBOXY-ETHYL)-ALPHA-(S)-(2-PHENYLETHYL)GLYCYL-L-ARGININE-N-PHENYLAMIDE	A	3BG8	0.71
DRC	9-AMINO-N-[2-(4-MORPHOLINYL)ETHYL]-4-ACRIDINECARBOXAMIDE	A	1KCI	0.71
LFN	LUMIFLAVIN	A	2CCC	0.72
NCE	3,6-Bis[(3-morpholinopropionamido)] acridine	A,B	3EM2	0.73
RBF	RIBOFLAVINE	B,D,F,H	2FL5	0.7
RBF	RIBOFLAVINE	A	2CC8	0.7
RBF	RIBOFLAVINE	A,B	1PKV	0.7
RBF	RIBOFLAVINE	A,B	1T6Z	0.7
RBF	RIBOFLAVINE	A	2VX9	0.7
RBF	RIBOFLAVINE	A,B,C,D,E	1KYV	0.7
RBF	RIBOFLAVINE	A	1MOG	0.7
RBF	RIBOFLAVINE	A,B,C,D,E,F,G,H,I,J,K,L	2VXA	0.7
RBF	RIBOFLAVINE	A,B	1L5R	0.7
RBF	RIBOFLAVINE	A,B	1HZE	0.7
RBF	RIBOFLAVINE	A,B,C,D,E	2A58	0.7
RBF	RIBOFLAVINE	A,B	1BU5	0.7
RBF	RIBOFLAVINE	X,Y	3F4G	0.7
RBF	RIBOFLAVINE	A	1NB9	0.7
RBF	RIBOFLAVINE	A,B	1I18	0.7
RBF	RIBOFLAVINE	A	3DDY	0.7
RBF	RIBOFLAVINE	A	2CCB	0.7
EOT	[(1-[(BIS-CARBOXYMETHYL-AMINO)-METHYL]-2-{4-[3-(2-HYDROXY-ETHYL)-THIOUREIDO]-PHENY}-ETHYL)-CARBOXYMETHYL-AMINO]-ACETIC ACID	H	1INE	0.72
EOT	[(1-[(BIS-CARBOXYMETHYL-AMINO)-METHYL]-2-{4-[3-(2-HYDROXY-ETHYL)-THIOUREIDO]-PHENY}-ETHYL)-CARBOXYMETHYL-AMINO]-ACETIC ACID	H	1IND	0.72
CF4	[4-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)butyl]carbamic acid	A	2VKG	0.73
529	(2S)-N-[(3Z)-5-CYCLOPROPYL-3H-PYRAZOL-3-YLIDENE]-2-[4-(2-OXOIMIDAZOLIDIN-1-YL)PHENYL]PROPANAMIDE	A,C,D	2BPM	0.73
D5G	(2S)-4-METHYL-2-(3-PHENYLTHIOUREIDO)-N-((3S)-TETRAHYDRO-2-HYDROXY-3-FURANYL)PENTANAMIDE	A	2G8E	0.71
IRF	1-DEOXY-1-(8-IODO-7-METHYL-2,4-DIOXO-3,4-DIHYDROBENZO[G]PTERIDIN-10(2H)-YL)-D-RIBITOL	A	2J08	0.7
SX6	N-(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)-4-morpholin-4-yl-4-oxobutanamide	A,B	3CJ5	0.73
SII	N-(4-{[4-(cyclohexylamino)-1-(3-fluorophenyl)-2-oxo-1,3,8-triazaspiro[4.5]dec-3-en-8-yl]methyl}phenyl)acetamide	A	3FKT	0.74
SLD	(3Z)-N-[(4E)-5-(4-{(5S)-5-[(acetylamino)methyl]-2-oxo-1,3-oxazolidin-3-yl}-2-fluorophenyl)pent-4-en-1-yl]-3-(4-methyl-2,6-dioxo-1,6-dihydropyrimidin-5(2H)-ylidene)propanamide	0,2,4,9,A,B,C,H,I,J,K,L,M,N,P,Q,R,S,T,X,Y,Z	3CXC	0.79
SC5	2-[((R)-{[4-(AMINOMETHYL)PHENYL]AMINO}{[(1R)-1-PHENYLETHYL]AMINO}METHYL)AMINO]ETHANE-1,1-DIOL	H	1YNK	0.71
Y14	N-[(1S)-2-{[(3S)-1-benzyl-3-cyanopyrrolidin-3-yl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide	A,B	2R9N	0.71